[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.193.74. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Download PDF
Figure. Flowchart of study participants.

Figure. Flowchart of study participants.

Table 1. Baseline Characteristics by Supplementation Group
Table 1. Baseline Characteristics by Supplementation Group
Table 2. Baseline Characteristics by Sex and Supplementation Group
Table 2. Baseline Characteristics by Sex and Supplementation Group
Table 3. Baseline Characteristics by Cancer Statusa
Table 3. Baseline Characteristics by Cancer Statusa
Table 4. Cox Proportional Hazards Analysis of Cancer Incidence and Mortality After 5 Years of Supplementation With B Vitamins and/or ω-3 Fatty Acids
Table 4. Cox Proportional Hazards Analysis of Cancer Incidence and Mortality After 5 Years of Supplementation With B Vitamins and/or ω-3 Fatty Acids
1.
American Cancer Society.  Cancer Facts & Figures 2011. Atlanta, GA: American Cancer Society; 2011
2.
World Cancer Research Fund, American Institute for Cancer Research.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007
3.
Liu L, Wylie RC, Andrews LG, Tollefsbol TO. Aging, cancer and nutrition: the DNA methylation connection.  Mech Ageing Dev. 2003;124(10-12):989-998PubMedArticle
4.
Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme.  J Nutr. 2000;130(2):129-132PubMed
5.
Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications.  J Nutr Biochem. 1999;10(2):66-88PubMedArticle
6.
Kim DH, Smith-Warner SA, Spiegelman D,  et al.  Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer.  Cancer Causes Control. 2010;21(11):1919-1930PubMedArticle
7.
Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies.  JAMA. 2010;303(11):1077-1083PubMedArticle
8.
Buhr G, Bales CW. Nutritional supplements for older adults: review and recommendations, part II.  J Nutr Elder. 2010;29(1):42-71PubMedArticle
9.
Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach.  Int J Cancer. 2005;113(5):825-828PubMedArticle
10.
World Cancer Research Fund, American Institute for Cancer Research.  Continuous Update Project Interim Report Summary: Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. Washington, DC: American Institute for Cancer Research; 2011
11.
Bollheimer LC, Buettner R, Kullmann A, Kullmann F. Folate and its preventive potential in colorectal carcinogenesis: how strong is the biological and epidemiological evidence?  Crit Rev Oncol Hematol. 2005;55(1):13-36PubMedArticle
12.
Zhu S, Mason J, Shi Y,  et al.  The effect of folic acid on the development of stomach and other gastrointestinal cancers.  Chin Med J (Engl). 2003;116(1):15-19PubMed
13.
Cole BF, Baron JA, Sandler RS,  et al; Polyp Prevention Study Group.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.  JAMA. 2007;297(21):2351-2359PubMedArticle
14.
Ebbing M, Bønaa KH, Nygård O,  et al.  Cancer incidence and mortality after treatment with folic acid and vitamin B12 JAMA. 2009;302(19):2119-2126PubMedArticle
15.
Clarke R, Halsey J, Lewington S,  et al; B-Vitamin Treatment Trialists' Collaboration.  Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals.  Arch Intern Med. 2010;170(18):1622-1631PubMedArticle
16.
Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain ω-3 fatty acids for the prevention of cancer: a review of potential mechanisms.  Am J Clin Nutr. 2004;79(6):935-945PubMed
17.
Roynette CE, Calder PC, Dupertuis YM, Pichard C. ω-3 Polyunsaturated fatty acids and colon cancer prevention.  Clin Nutr. 2004;23(2):139-151PubMedArticle
18.
Rhodes LE, Shahbakhti H, Azurdia RM,  et al.  Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans: an assessment of early genotoxic markers.  Carcinogenesis. 2003;24(5):919-925PubMedArticle
19.
Geelen A, Schouten JM, Kamphuis C,  et al.  Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies.  Am J Epidemiol. 2007;166(10):1116-1125PubMedArticle
20.
Hooper L, Thompson RL, Harrison RA,  et al.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.  BMJ. 2006;332(7544):752-760PubMedArticle
21.
MacLean CH, Newberry SJ, Mojica WA,  et al.  Effects of omega-3 fatty acids on cancer risk: a systematic review [published correction appears in JAMA. 2006;295(16):1900].  JAMA. 2006;295(4):403-415PubMedArticle
22.
Terry PD, Terry JB, Rohan TE. Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research.  J Nutr. 2004;134(12):(suppl)  3412S-3420SPubMed
23.
Galan P, Briancon S, Blacher J, Czernichow S, Hercberg S. The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics.  Trials. 2008;9:35PubMedArticleArticle
24.
Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S.SU.FOL.OM3 Collaborative Group.  Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.  BMJ. 2010;341:c6273PubMedArticleArticle
25.
de Bree A, Mennen LI, Hercberg S, Galan P. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.  Eur J Clin Nutr. 2004;58(5):732-744PubMedArticle
26.
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Armitage JM, Bowman L, Clarke RJ,  et al.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.  JAMA. 2010;303(24):2486-2494PubMedArticle
27.
Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits.  Am J Clin Nutr. 1996;64(4):587-593PubMed
28.
McKay JA, Williams EA, Mathers JC. Gender-specific modulation of tumorigenesis by folic acid supply in the APC+/Min mouse during early neonatal life.  Br J Nutr. 2008;99(3):550-558PubMedArticle
29.
Kim YI. Does a high folate intake increase the risk of breast cancer?  Nutr Rev. 2006;64(10, pt 1):468-475PubMedArticle
30.
Stripp C, Overvad K, Christensen J,  et al.  Fish intake is positively associated with breast cancer incidence rate.  J Nutr. 2003;133(11):3664-3669PubMed
31.
Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers.  Carcinogenesis. 1999;20(12):2209-2218PubMedArticle
32.
Theodoratou E, McNeill G, Cetnarskyj R,  et al.  Dietary fatty acids and colorectal cancer: a case-control study.  Am J Epidemiol. 2007;166(2):181-195PubMedArticle
Original Investigation
Apr 9, 2012

B Vitamin and/or ω-3 Fatty Acid Supplementation and CancerAncillary Findings From the Supplementation With Folate, Vitamins B6 and B12, and/or Omega-3 Fatty Acids (SU.FOL.OM3) Randomized Trial

Author Affiliations

Author Affiliations: Nutritional Epidemiology Research Unit, Unité Mixte de Recherche, Institut National de la Santé et de la Recherche Médicale U557, U1125 Institut National de la Recherche Agronomique, Conservatoire National des Arts et Métiers, University of Paris XIII (Drs Andreeva, Touvier, Kesse-Guyot, Julia, Galan, and Hercberg), and Department of Public Health, Avicenne Hospital (Dr Hercberg), Bobigny, France.

Arch Intern Med. 2012;172(7):540-547. doi:10.1001/archinternmed.2011.1450
×